862255-56-9 Usage
Uses
Used in Pharmaceutical Industry:
Benzeneethanol, 2,5-difluorois used as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure and reactivity make it a valuable building block for the development of new drugs and medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical industry, Benzeneethanol, 2,5-difluorois used as a precursor for the production of various agrochemicals, including pesticides and herbicides. Its unique properties allow for the development of more effective and targeted agrochemical products.
Used in Specialty Chemical Industry:
Benzeneethanol, 2,5-difluorois used as a key component in the development of specialty chemicals, such as fluorinated compounds and other advanced materials. Its unique chemical properties make it an essential building block for creating innovative and high-performance specialty chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 862255-56-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,2,5 and 5 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 862255-56:
(8*8)+(7*6)+(6*2)+(5*2)+(4*5)+(3*5)+(2*5)+(1*6)=179
179 % 10 = 9
So 862255-56-9 is a valid CAS Registry Number.
862255-56-9Relevant articles and documents
NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF
-
Paragraph 00241, (2020/12/01)
The invention provides compounds for inhibiting glucosylceramidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds.
3,3-DIFLUORO-PIPERIDINE DERIVATIVES AS NR2B NMDA RECEPTOR ANTAGONISTS
-
, (2016/09/22)
Disclosed are chemical entities of Formula (I): wherein X, Y, Z, R1, R3, R4 and R5 are defined herein, as NR2B subtype selective receptor antagonists. Also disclosed are pharmaceutical compositions comprising a chemical entity of Formula (I), and methods of treating various diseases and disorders associated with NR2B antagonism, e.g., diseases and disorders of the CNS, such as depression, by administering a chemical entity of Formula (I).
